AI assistant
Sending…
Ocugen, Inc. — Director's Dealing 2019
Oct 4, 2019
32915_dirs_2019-10-04_058d40be-54d2-4e5e-9256-5e79a13b1421.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2019-09-27
Reporting Person: Zhang Junge (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 212863 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrants (Right to Buy) | $2.77 | 2025-01-10 | Common Stock (143820) | Indirect | |
| Warrants (Right to Buy) | $7.56 | 2027-06-12 | Common Stock (1653) | Indirect |
More from Ocugen, Inc.
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Mar 20
Annual Report
2026
Mar 4
Regulatory Filings
2026
Mar 4